Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly loss of chromosome 17p. (A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 17 (17p).)
Biomarker and diagnostic research for acute myeloid leukemia, loss of chromosome 17p has been reported in the published literature.
No clinical trials have been registered for acute myeloid leukemia, loss of chromosome 17p.
13 publications have been identified in PubMed for acute myeloid leukemia, loss of chromosome 17p. Research spans Case Report / Case Series (31%), Diagnostic / Biomarker (15%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 31% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:41 PM UTC
Common questions about acute myeloid leukemia, loss of chromosome 17p
Testing and diagnosis research
2 |
15% |
Laboratory research | 2 | 15% |
Disease patterns and progression | 2 | 15% |
Research summaries | 1 | 8% |
Clinical study results | 1 | 8% |
New treatment approaches | 1 | 8% |
Fang Q (2026). [PMID: 41399202](https://pubmed.ncbi.nlm.nih.gov/41399202/). *Hematology (Amsterdam, Netherlands)*. [Diagnostic / Biomarker]
Hamilton RM (2026). [PMID: 41635182](https://pubmed.ncbi.nlm.nih.gov/41635182/). *Cytometry. Part A : the journal of the International Society for Analytical Cytology*. [Diagnostic / Biomarker]
Drekolias D (2026). [PMID: 41671569](https://pubmed.ncbi.nlm.nih.gov/41671569/). *Blood cancer discovery*. [Clinical Trial Publication]
Kawamura M (2026). [PMID: 41584902](https://pubmed.ncbi.nlm.nih.gov/41584902/). *EJHaem*. [Case Report / Case Series]
Spinella JF (2026). [PMID: 42139355](https://pubmed.ncbi.nlm.nih.gov/42139355/). *Sci Adv*. [Basic Science / Preclinical]
Sathyanarayana SH (2025). [PMID: 39999580](https://pubmed.ncbi.nlm.nih.gov/39999580/). *Cancer genetics*. [Case Report / Case Series]
Liu Y (2025). [PMID: 38824913](https://pubmed.ncbi.nlm.nih.gov/38824913/). *Acta haematologica*. [Case Report / Case Series]
Senagolage MD (2025). [PMID: 40792013](https://pubmed.ncbi.nlm.nih.gov/40792013/). *Blood neoplasia*. [Gene Therapy / Novel Therapeutics]
Nathan DI (2025). [PMID: 40505637](https://pubmed.ncbi.nlm.nih.gov/40505637/). *Acta haematologica*. [Basic Science / Preclinical]
Pandiri M (2025). [PMID: 40571403](https://pubmed.ncbi.nlm.nih.gov/40571403/). *Journal of clinical pathology*. [Epidemiology / Natural History]